Nephrotoxicity from chemotherapeutic agents: clinical manifestations, pathobiology, and prevention/therapy
- PMID: 21146122
- DOI: 10.1016/j.semnephrol.2010.09.005
Nephrotoxicity from chemotherapeutic agents: clinical manifestations, pathobiology, and prevention/therapy
Erratum in
- Semin Nephrol. 2011 May;31(3):317
Abstract
Nephrotoxicity remains a vexing complication of chemotherapeutic agents. A number of kidney lesions can result from these drugs, including primarily tubular-limited dysfunction, glomerular injury with proteinuria, full-blown acute kidney injury, and long-term chronic kidney injury. In most cases, these kidney lesions develop from innate toxicity of these medications, but underlying host risk factors and the renal handling of these drugs clearly increase the likelihood of nephrotoxicity. This article reviews some of the classic nephrotoxic chemotherapeutic agents and focuses on examples of the clinical and histopathologic kidney lesions they cause as well as measures that may prevent or treat drug-induced nephrotoxicity.
Copyright © 2010 Elsevier Inc. All rights reserved.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical